1986•Poultry ScienceOpen access

Efficacy of Coarse Spray Administration of Commercial Intermediate Infectious Bursal Disease Vaccines

JOSEPH J. GIAMBRONE, R.P. CLAY

Open full text 7 citations

Abstract

The efficacy of two intermediate infectious bursal disease (IBD) vaccines (Clone Vac D-78 and S-706) for immunizing specific pathogen-free (SPF) White Leghorn chickens by coarse spray (CS) against subclinical IBD was compared. Both intermediate IBD vaccines were equally capable of immunizing day-old SPF chickens by CS and were safe as evidenced by the absence of morbidity, mortality, or severe gross and microscopic bursal pathology at 28 days of age.

About this research paper

What this paper is about

The efficacy of two intermediate infectious bursal disease (IBD) vaccines (Clone Vac D-78 and S-706) for immunizing specific pathogen-free (SPF) White Leghorn chickens by coarse spray (CS) against subclinical IBD was compared. Both intermediate IBD vaccines were equally capable of immunizing day-old SPF chickens by CS and were safe as evidenced by the absence of morbidity, mortality, or severe gross and microscopic bursal pathology at 28 days of age.

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The efficacy of two intermediate infectious bursal disease (IBD) vaccines (Clone Vac D-78 and S-706) for immunizing specific pathogen-free (SPF) White Leghorn chickens by coarse spray (CS) against subclinical IBD was compared. Both intermediate IBD vaccines were equally capable of immunizing day-old SPF chickens by CS and were safe as evidenced by the absence of morbidity, mortality, or severe gross and microscopic bursal pathology at 28 days of age.

Key concepts: Infectious bursal disease, Specific-pathogen-free, Subclinical infection, Pathogen, Medicine, clone (Java method), Virology, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy of Coarse Spray Administration of Commercial Intermediate Infectious Bursal Disease Vaccines — Research Paper | ScholarLens